Literature DB >> 27521520

Molecular basis for the genome engagement by Sox proteins.

Linlin Hou1, Yogesh Srivastava1, Ralf Jauch2.   

Abstract

The Sox transcription factor family consists of 20 members in the human genome. Many of them are key determinants of cellular identities and possess the capacity to reprogram cell fates by pioneering the epigenetic remodeling of the genome. This activity is intimately tied to their ability to specifically bind and bend DNA alone or with other proteins. Here we discuss our current knowledge on how Sox transcription factors such as Sox2, Sox17, Sox18 and Sox9 'read' the genome to find and regulate their target genes and highlight the roles of partner factors including Pax6, Nanog, Oct4 and Brn2. We integrate insights from structural and biochemical studies as well as high-throughput assays to probe DNA specificity in vitro as well as in cells and tissues.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cellular reprogramming; DNA binding; Gene regulation; Sox; Transcription factors

Mesh:

Substances:

Year:  2016        PMID: 27521520     DOI: 10.1016/j.semcdb.2016.08.005

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  39 in total

Review 1.  Genetics and Other Omics in Pediatric Pulmonary Arterial Hypertension.

Authors:  Carrie L Welch; Wendy K Chung
Journal:  Chest       Date:  2020-01-30       Impact factor: 9.410

2.  Nucleosome allostery in pioneer transcription factor binding.

Authors:  Cheng Tan; Shoji Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-10       Impact factor: 11.205

Review 3.  Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.

Authors:  Vikas Malik; Dennis Zimmer; Ralf Jauch
Journal:  Cell Mol Life Sci       Date:  2018-01-15       Impact factor: 9.261

Review 4.  SOXopathies: Growing Family of Developmental Disorders Due to SOX Mutations.

Authors:  Marco Angelozzi; Véronique Lefebvre
Journal:  Trends Genet       Date:  2019-07-06       Impact factor: 11.639

5.  SOX12 expression is associated with progression and poor prognosis in human breast cancer.

Authors:  Junming Xu; Jinyan Zhang; Lei Li; Jieqi Mao; Tiangeng You; Yang Li
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

6.  SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.

Authors:  Chia-Feng Liu; Marco Angelozzi; Abdul Haseeb; Véronique Lefebvre
Journal:  Development       Date:  2018-07-18       Impact factor: 6.868

7.  Quantitative profiling of selective Sox/POU pairing on hundreds of sequences in parallel by Coop-seq.

Authors:  Yiming K Chang; Yogesh Srivastava; Caizhen Hu; Adam Joyce; Xiaoxiao Yang; Zheng Zuo; James J Havranek; Gary D Stormo; Ralf Jauch
Journal:  Nucleic Acids Res       Date:  2016-12-02       Impact factor: 16.971

8.  De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with Mild Dysmorphism.

Authors:  Ash Zawerton; Baojin Yao; J Paige Yeager; Tommaso Pippucci; Abdul Haseeb; Joshua D Smith; Lisa Wischmann; Susanne J Kühl; John C S Dean; Daniela T Pilz; Susan E Holder; Alisdair McNeill; Claudio Graziano; Véronique Lefebvre
Journal:  Am J Hum Genet       Date:  2019-01-17       Impact factor: 11.025

Review 9.  Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.

Authors:  Carrie L Welch; Eric D Austin; Wendy K Chung
Journal:  Pediatr Pulmonol       Date:  2020-01-09

10.  Targeted DamID reveals differential binding of mammalian pluripotency factors.

Authors:  Seth W Cheetham; Wolfram H Gruhn; Jelle van den Ameele; Robert Krautz; Tony D Southall; Toshihiro Kobayashi; M Azim Surani; Andrea H Brand
Journal:  Development       Date:  2018-10-17       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.